Search

Steven B. Wong

Examiner (ID: 12169, Phone: (571)272-4416 , Office: P/3711 )

Most Active Art Unit
3711
Art Unit(s)
2899, 1304, 3304, 3711
Total Applications
2939
Issued Applications
1770
Pending Applications
164
Abandoned Applications
1020

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7207108 [patent_doc_number] => 20050043336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Quinazoline derivatives as antitumor agents' [patent_app_type] => utility [patent_app_number] => 10/494137 [patent_app_country] => US [patent_app_date] => 2002-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 71621 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043336.pdf [firstpage_image] =>[orig_patent_app_number] => 10494137 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/494137
Quinazoline derivatives as antitumor agents Oct 30, 2002 Abandoned
Array ( [id] => 7216726 [patent_doc_number] => 20050054662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Quinazoline derivatives as antitumor agents' [patent_app_type] => utility [patent_app_number] => 10/494388 [patent_app_country] => US [patent_app_date] => 2002-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 89003 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054662.pdf [firstpage_image] =>[orig_patent_app_number] => 10494388 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/494388
Quinazoline derivatives as antitumor agents Oct 30, 2002 Abandoned
Array ( [id] => 7380059 [patent_doc_number] => 20040220404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Pyrimidinones as melanin concentrating hormone receptor 1' [patent_app_type] => new [patent_app_number] => 10/492641 [patent_app_country] => US [patent_app_date] => 2004-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31406 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220404.pdf [firstpage_image] =>[orig_patent_app_number] => 10492641 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/492641
Pyrimidinones as melanin concentrating hormone receptor 1 Oct 14, 2002 Issued
Array ( [id] => 6651611 [patent_doc_number] => 20030105087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => ' New polycyclic azaindole compounds' [patent_app_type] => new [patent_app_number] => 10/267303 [patent_app_country] => US [patent_app_date] => 2002-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14715 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105087.pdf [firstpage_image] =>[orig_patent_app_number] => 10267303 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/267303
Polycyclic azaindole compounds Oct 8, 2002 Issued
Array ( [id] => 185604 [patent_doc_number] => 07645878 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-12 [patent_title] => 'Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof' [patent_app_type] => utility [patent_app_number] => 10/252369 [patent_app_country] => US [patent_app_date] => 2002-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13561 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/645/07645878.pdf [firstpage_image] =>[orig_patent_app_number] => 10252369 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/252369
Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof Sep 23, 2002 Issued
Array ( [id] => 6797823 [patent_doc_number] => 20030176697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Method for preparing crambescidin core acid intermediates and their use for preparing crambescidin alkaloid analogs as therapeutic agents' [patent_app_type] => new [patent_app_number] => 10/255994 [patent_app_country] => US [patent_app_date] => 2002-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11827 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176697.pdf [firstpage_image] =>[orig_patent_app_number] => 10255994 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/255994
Method for preparing crambescidin core acid intermediates and their use for preparing crambescidin alkaloid analogs as therapeutic agents Sep 23, 2002 Abandoned
Array ( [id] => 6852105 [patent_doc_number] => 20030144308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Fructose 1,6-bisphosphatase inhibitors' [patent_app_type] => new [patent_app_number] => 10/251073 [patent_app_country] => US [patent_app_date] => 2002-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19072 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144308.pdf [firstpage_image] =>[orig_patent_app_number] => 10251073 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/251073
Fructose 1,6-bisphosphatase inhibitors Sep 19, 2002 Abandoned
Array ( [id] => 6835249 [patent_doc_number] => 20030162795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Thienopyrimidine and thienopyridine derivatives useful as anticancer agents' [patent_app_type] => new [patent_app_number] => 10/244324 [patent_app_country] => US [patent_app_date] => 2002-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35409 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162795.pdf [firstpage_image] =>[orig_patent_app_number] => 10244324 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/244324
Thienopyrimidine and thienopyridine derivatives useful as anticancer agents Sep 15, 2002 Abandoned
Array ( [id] => 7389031 [patent_doc_number] => 20040030129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'NF-kappaB inhibitor comprising phenylmethyl benzoquinone as an active ingredient' [patent_app_type] => new [patent_app_number] => 10/243737 [patent_app_country] => US [patent_app_date] => 2002-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 31797 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20040030129.pdf [firstpage_image] =>[orig_patent_app_number] => 10243737 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/243737
NF-kappaB inhibitor comprising phenylmethyl benzoquinone as an active ingredient Sep 15, 2002 Abandoned
Array ( [id] => 6684021 [patent_doc_number] => 20030119885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => ' CCR-3 receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/242610 [patent_app_country] => US [patent_app_date] => 2002-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10904 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119885.pdf [firstpage_image] =>[orig_patent_app_number] => 10242610 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/242610
CCR-3 receptor antagonists Sep 11, 2002 Issued
Array ( [id] => 6683970 [patent_doc_number] => 20030119834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Compositions and methods of treatment of cancer' [patent_app_type] => new [patent_app_number] => 10/236863 [patent_app_country] => US [patent_app_date] => 2002-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10060 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119834.pdf [firstpage_image] =>[orig_patent_app_number] => 10236863 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/236863
Compositions and methods of treatment of cancer Sep 4, 2002 Abandoned
Array ( [id] => 1178187 [patent_doc_number] => 06743801 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-01 [patent_title] => '1,2,3,6-tetrahydropyrimidine-2-one compositions and therapeutic methods therewith for pain and inflammation' [patent_app_type] => B2 [patent_app_number] => 10/232798 [patent_app_country] => US [patent_app_date] => 2002-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7511 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/743/06743801.pdf [firstpage_image] =>[orig_patent_app_number] => 10232798 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/232798
1,2,3,6-tetrahydropyrimidine-2-one compositions and therapeutic methods therewith for pain and inflammation Aug 28, 2002 Issued
Array ( [id] => 6745706 [patent_doc_number] => 20030022889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Method for providing neuro-protective effects' [patent_app_type] => new [patent_app_number] => 10/228618 [patent_app_country] => US [patent_app_date] => 2002-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4365 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022889.pdf [firstpage_image] =>[orig_patent_app_number] => 10228618 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/228618
Method for providing neuro-protective effects Aug 26, 2002 Abandoned
Array ( [id] => 6653250 [patent_doc_number] => 20030008866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Bicyclic inhibitors of glycogen synthase kinase 3' [patent_app_type] => new [patent_app_number] => 10/228621 [patent_app_country] => US [patent_app_date] => 2002-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16236 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008866.pdf [firstpage_image] =>[orig_patent_app_number] => 10228621 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/228621
Bicyclic inhibitors of glycogen synthase kinase 3 Aug 25, 2002 Abandoned
Array ( [id] => 910424 [patent_doc_number] => 07329665 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-12 [patent_title] => 'Quinazolinone derivative' [patent_app_type] => utility [patent_app_number] => 10/485865 [patent_app_country] => US [patent_app_date] => 2002-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4398 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/329/07329665.pdf [firstpage_image] =>[orig_patent_app_number] => 10485865 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/485865
Quinazolinone derivative Aug 1, 2002 Issued
10/129017 Isoquinoline and quinazoline derivatives for the treatment of cns disorders Jul 31, 2002 Abandoned
Array ( [id] => 1102736 [patent_doc_number] => 06811357 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-02 [patent_title] => 'Retaining wall assembly' [patent_app_type] => B1 [patent_app_number] => 10/207751 [patent_app_country] => US [patent_app_date] => 2002-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 1562 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/811/06811357.pdf [firstpage_image] =>[orig_patent_app_number] => 10207751 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/207751
Retaining wall assembly Jul 29, 2002 Issued
Array ( [id] => 6689080 [patent_doc_number] => 20030032805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Process for the preparation of high purity pemirolast' [patent_app_type] => new [patent_app_number] => 10/196260 [patent_app_country] => US [patent_app_date] => 2002-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 706 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032805.pdf [firstpage_image] =>[orig_patent_app_number] => 10196260 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/196260
Process for the preparation of high purity Pemirolast Jul 16, 2002 Issued
10/129035 Isoquinoline and quinazoline derivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity Jul 15, 2002 Abandoned
Array ( [id] => 6801641 [patent_doc_number] => 20030096806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Arylphenyl-substituted cyclic ketoenols' [patent_app_type] => new [patent_app_number] => 10/192361 [patent_app_country] => US [patent_app_date] => 2002-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31918 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096806.pdf [firstpage_image] =>[orig_patent_app_number] => 10192361 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/192361
Arylphenyl-substituted cyclic ketoenols Jul 9, 2002 Abandoned
Menu